Aryl hydrocarbon receptor-mediated inhibition of LNCaP prostate cancer cell growth and hormone-induced transactivation
- 1 January 2004
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 88 (1) , 27-36
- https://doi.org/10.1016/j.jsbmb.2003.10.005
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Stabilization of androgen receptor protein is induced by agonist, not by antagonistsBiochemical and Biophysical Research Communications, 2002
- Expression of prostate‐specific antigen is transcriptionally regulated by genistein in prostate cancer cellsMolecular Carcinogenesis, 2002
- Inhibiting Proteasomes in Human HepG2 and LNCaP Cells Increases Endogenous Androgen Receptor LevelsBiochemical and Biophysical Research Communications, 2000
- Cross-Talk between 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Testosterone Signal Transduction Pathways in LNCaP Prostate Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Characterization of the molecular and structural properties of the transformed and nuclear aryl hydrocarbon (Ah) receptor complexes by proteolytic digestionChemico-Biological Interactions, 1996
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) is an antiestrogen in human and rodent cancer cell lines: Evidence for the role of the Ah receptorToxicology and Applied Pharmacology, 1992
- 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 miceToxicology, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971